Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,775 total articles

Uniti Solutions Recognized as Americas Service Provider of the Year for 2026 Cato Networks Americas Partner Awards

Uniti Solutions Recognized as Americas Service Provider of the Year for 2026 Cato Networks Americas Partner Awards

Uniti Solutions, a business unit of Uniti, has been awarded the Americas Service Provider of the Year at the 2026 Cato Networks Americas Partner Awards for the second year in a row. The recognition highlights their effective collaboration in delivering managed SASE services powered by Cato's SASE platform, improving secure networking for their cust…

NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia

NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia

NervGen Pharma announced the successful conclusion of the End-of-Phase 2 meeting with the FDA, securing alignment on the RESTORE Phase 3 registrational study evaluating NVG-291 for chronic tetraplegia. The FDA-endorsed study design includes a functional primary endpoint focused on hand use improvement, with initiation planned for mid-2026. Positive…

CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting

CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting

CervoMed Inc. announced new MRI analysis findings from its Phase 2b RewinD-LB clinical trial showing potential benefits of neflamapimod in reducing basal forebrain atrophy in DLB patients. The company also reported alignment with global regulatory authorities on its Phase 3 trial design and highlighted neflamapimod's potential as the first approved…

Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales

Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales

Palvella Therapeutics announced the appointment of Kent Taylor as Senior Vice President of Sales to spearhead the U.S. sales organization in preparation for the potential launch of QTORIN™ rapamycin, targeting rare, serious skin diseases and vascular malformations. Taylor brings over 25 years of pharmaceutical sales leadership, including successful…

Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption

Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption

Plus Therapeutics announced that the American Medical Association has granted a new Proprietary Laboratory Analyses (PLA) code 0640U for its CNSide® CSF Tumor Cell Enumeration test, facilitating reimbursement and supporting the commercial launch in the U.S. This coding milestone is expected to enhance payer coverage, clinical adoption, and revenue …

Creative Realities, Inc. Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call Information

Creative Realities, Inc. Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call Information

Creative Realities, Inc., a Nasdaq-listed provider of digital signage, media and AdTech solutions, announced it will release its financial results for the quarter and full year ended December 31, 2025, on April 14, 2026, prior to market open. The company will host a conference call with management to discuss the results and business outlook. The an…

Akamai Technologies To Hold First Quarter 2026 Investor Conference Call On Thursday, May 7, at 4:30 PM ET

Akamai Technologies To Hold First Quarter 2026 Investor Conference Call On Thursday, May 7, at 4:30 PM ET

Akamai Technologies announced it will hold its first quarter 2026 earnings conference call on May 7, 2026, at 4:30 p.m. ET. The call will cover the company's financial results for Q1 2026 and may include forward-looking guidance from management. The event will be accessible via live dial-in and webcast, with a replay available for two weeks followi…

Galveston Police Department Adopts Non-Lethal Response Solutions with Purchase of BolaWrap® Devices and WrapTactics™ Subscription, Supported by In-Person Training as Part of Broader NLR Strategy

Galveston Police Department Adopts Non-Lethal Response Solutions with Purchase of BolaWrap® Devices and WrapTactics™ Subscription, Supported by In-Person Training as Part of Broader NLR Strategy

Wrap Technologies, Inc. announced that the Galveston Police Department has adopted its non-lethal response solutions by purchasing BolaWrap 150 devices and subscribing to WrapTactics training, supported by in-person training sessions. This move aims to enhance the department's capabilities in managing critical incidents with safer, non-lethal tools…

Toll Brothers Announces Final Opportunity for Luxury Living at Toll Brothers at StoneCreek in Richmond, Texas

Toll Brothers Announces Final Opportunity for Luxury Living at Toll Brothers at StoneCreek in Richmond, Texas

Toll Brothers, the leading luxury home builder listed on NYSE as TOL, announced the final availability of quick move-in luxury homes at their StoneCreek community in Richmond, Texas. The neighborhood features elegant homes with resort-style amenities and convenient access to Houston, targeting families and professionals seeking upscale living.

Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness

Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness

Emergent BioSolutions launches a compact, durable carrying case for NARCAN nasal spray and expands multipack options to improve accessibility of its opioid overdose reversal product. The company also initiates a college campus campaign featuring Emmitt Smith to promote overdose preparedness, targeting high-risk young adults and encouraging wider ca…

Dillard’s Introduces Cyd Morris x Gianni Bini

Dillard’s Introduces Cyd Morris x Gianni Bini

Dillard's, Inc. (NYSE: DDS) announced a new collaboration with designer Cydney Morris to create the limited-edition Cyd Morris x Gianni Bini capsule collection. The exclusive collection features apparel and accessories inspired by coastal nostalgia and is available only at Dillard's stores and online. This partnership enriches Dillard's contemporar…

Oportun Celebrates “20 Years, One Mission” of Empowering Members to Build a Better Financial Future

Oportun Celebrates “20 Years, One Mission” of Empowering Members to Build a Better Financial Future

Oportun celebrates its 20th anniversary, highlighting two decades of providing affordable, responsible credit and financial tools to underserved communities in the U.S. The company has issued over 8 million loans and credit cards totaling more than $22 billion, helped 1.3 million members build credit, and saved members billions in interest and fees…

Solid Biosciences to Participate at Upcoming Investor Conferences

Solid Biosciences to Participate at Upcoming Investor Conferences

Solid Biosciences Inc., a precision genetic medicine company focused on neuromuscular and cardiac diseases, announced its participation in the 25th Annual Needham Virtual Healthcare Conference and the Piper Sandler Spring Biopharma Symposium in April 2026. CEO Bo Cumbo will present in a virtual fireside chat, and management will hold one-on-one inv…